Lyme Disease Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Lyme Disease Treatment Market is expected to garner $1,062,794.78 thousand by 2028, growing at a CAGR of 7% during the forecast period 2022 to 2028.

Lyme disease is an infectious disease caused by a bacterium called Borrelia burgdorferi that is transmitted to humans by the bite of an infected adult black-legged tick. Most human infections result from the bite of a nymph (immature tick). Ticks can attach to any part of the body and can transmit an infection when attached to a host for 36 to 48 hours. Black-legged tick causes Lyme disease in the Northeastern, Mid-Atlantic, and North-Central regions of the United States, while the western black-legged tick spreads Lyme disease in the Pacific Coast. Therefore, this region is expected to witness rapid growth of the Lyme disease treatment market in the near future.

Market Segments

By Disease Type

  • Early Lyme disease (absence of erythema migrans)
  • Lyme carditis
  • Lyme arthritis
  • neurologic Lyme disease
  • Borrelial lymphocytosis
  • Post-treatment Lyme Disease Syndrome (PTLDS)

By Treatment

  • Doxycycline
  • Amoxicillin
  • Cefuroxime axetil
  • Ceftriaxone

Key Players

  • GlaxoSmithKline plc
  • Pfizer, Inc.
  • Novartis AG
  • Hoffmann-La Roche Ltd.
  • Almirall, LLC
  • Mayne Pharma
  • Boehringer Ingelheim International GmbH
  • Galderma Laboratories, L.P.
  • Lupin Pharmaceuticals, Inc.
  • Chartwell Pharmaceuticals
  • Sun Pharmaceutical Industries Ltd.
  • Perrigo Company plc
  • Orion Corporation
  • Amneal Pharmaceuticals LLC.

Scope of the Report

The research study analyzes the global Lyme Disease Treatment industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Lyme Disease Treatment Market Report

1. What was the Lyme Disease Treatment Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Lyme Disease Treatment Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Lyme Disease Treatment Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

The report will be delivered within 48-72 hours after payment confirmation